This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: New York University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Andrew S Chi in Therapeutic Agents
Introduction
Andrew S Chi is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of therapeutic agents. His work focuses on innovative compounds that have the potential to treat diseases related to nicotinamide phosphoribosyltransferase (NAMPT) expression.
Latest Patents
Andrew S Chi holds a patent for "Fused bicyclic heterocycles as therapeutic agents." This patent relates to compounds and pharmaceutical compositions that can be used for treating diseases associated with NAMPT expression. The disclosure emphasizes the importance of fused bicyclic heterocyclic compounds and outlines methods for inhibiting NAMPT using these innovative compounds.
Career Highlights
Andrew S Chi is affiliated with New York University, where he continues to advance his research in the pharmaceutical field. His dedication to innovation has led to the development of new therapeutic strategies that could significantly impact patient care.
Collaborations
Some of his notable coworkers include John K Dickson and Xinyan Huang. Their collaborative efforts contribute to the ongoing research and development of new therapeutic agents.
Conclusion
Andrew S Chi's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to the development of therapeutic agents highlight the potential for new treatments that can improve health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile